Akero Therapeutics Inc (AKRO)
39.14
-1.34
(-3.31%)
USD |
NASDAQ |
Apr 01, 15:20
Akero Therapeutics Shareholders Equity (Quarterly): 750.11M for Dec. 31, 2024
View 4,000+ Financial Data Types:
Add
Browse
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| 89bio Inc | 400.79M |
| Biogen Inc | 16.72B |
| Cytokinetics Inc | -135.37M |
| Sage Therapeutics Inc | 465.09M |
| Allakos Inc | 78.82M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 825.89M |
| Total Liabilities (Quarterly) | 75.77M |